Year in Review: Biotech Innovation, Policy, and Global Competition

In this special holiday episode, the Making Medicine Podcast looks back at standout conversations since the show’s July relaunch, covering biotech innovation, research funding, and global competitiveness. Highlights include discussions with industry leaders on venture capital, R&D stability, manufacturing, and the importance of a connected life sciences ecosystem. The episode also revisits conversations on international competition, commercialization challenges, and how policy choices shape innovation outcomes. Together, these moments underscore why long-term investment and coordination across the value chain matter for patients and progress.Which conversation stood out most to you this year?What policy or innovation topic should we explore more deeply in 2026?How do you see global competition shaping the future of biotech?If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more: https://x.com/MakingMedPod https://www.instagram.com/makingmedicinepod/ https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=true Timestamps:0:00 Show disclaimer and welcome0:23 Holiday greeting and episode overview1:00 Industry snapshot and biotech competitiveness3:36 R&D funding, NIH, and innovation stability5:36 Global competition and maintaining leadership8:23 Risks and resilience of the innovation economy8:46 Policy ideas to support US biotech14:12 Global perspectives on commercialization and pricing17:20 Integrating early innovators and large pharma21:27 Policy, pricing, and innovation trade-offs27:37 IP, R&D incentives, and unintended consequences28:23 Closing reflections and looking ahead to 2026DISCLAIMER: We’re reporting on the headlines, not making medical recommendations. For personal health questions, always consult a doctor.